An Expert Group Consensus Statement on "Approach and Management of Prediabetes in India".


Journal

The Journal of the Association of Physicians of India
ISSN: 0004-5772
Titre abrégé: J Assoc Physicians India
Pays: India
ID NLM: 7505585

Informations de publication

Date de publication:
Dec 2022
Historique:
medline: 26 6 2023
pubmed: 25 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

The prevalence of prediabetes, a forerunner of diabetes is very high, and its conversion to diabetes is also more rapid among Asian Indians. Prediabetes also predisposes to the development of macrovascular and to a lesser extent of microvascular complications of diabetes. In a large community-based epidemiological study, the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB), data reported an overall prevalence of prediabetes of 10.3%, derived from 15 Indian states. This shows that the diabetes epidemic is far from over as many of them may soon convert to diabetes. Prediabetes, however, should not be considered a path to diabetes rather it should be a window of opportunity for the prevention of diabetes. This early screening, detection, and treatment of prediabetes should be made a national priority. Several countries have introduced lifestyle programs to prevent diabetes and, when indicated, pharmacological intervention with metformin as well. This consensus statement outlines the approaches to screening and lifestyle and pharmacological management of prediabetes in Asian Indians.

Identifiants

pubmed: 37355974
doi: 10.5005/japi-11001-0162
doi:

Substances chimiques

Metformin 9100L32L2N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-12

Informations de copyright

© Journal of the Association of Physicians of India 2011.

Auteurs

Ashok Kumar Das (AK)

Emeritus Professor, Mahatma Gandhi Medical College and Research Institute and SBV, Puducherry; Corresponding Author.

Viswanathan Mohan (V)

Director and Chief of Diabetes Research, Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre.

Ambady Ramachandran (A)

President, India Diabetes Research Foundation; Chairman, Dr. A. Ramachandran's Diabetes Hospitals, Chennai, Tamil Nadu.

Sanjay Kalra (S)

Consultant, Department of Endocrinology, Bharti Hospital, Karnal, Haryana.

Ambrish Mithal (A)

Chairman and Head, Endocrinology and Diabetology, Max Healthcare, New Delhi, Delhi.

Rakesh Sahay (R)

Professor of Endocrinology, Department of Endocrinology, Osmania Medical College, Hyderabad, Telangana.

Mangesh Tiwaskar (M)

Consultant Physician and Diabetologist, Department of Internal Medicine, Shilpa Medical Research Centre, Mumbai, Maharashtra.

Sambit Das (S)

Professor of Endocrinology, Hi-Tech Medical College & Hospital, Bhubaneshwar, Orissa.

Manash P Baruah (MP)

Consultant Endocrinologist, Excel care Hospitals, Guwahati, Assam.

Jubbin Jacob (J)

Professor and Head, Department of Endocrinology, Christian Medical College and Hospital, Ludhiana, Punjab.

Shehla Sheikh (S)

Consultant Endocrinologist, Prince Aly Khan Hospital and Saifee Hospital, Mumbai, Maharashtra.

Jothydev Kesavadav (J)

Diabetologist, Jothydev's Diabetes Research Center, Trivandrum, Kerala, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH